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Abstract
Mounting evidence suggests that Herpes simplex virus type 1 (HSV-1) is involved in the pathogenesis of Alzheimer’s disease
(AD). Previous work from our laboratory has shown HSV-1 infection to induce the most important pathological hallmarks of
AD brains. Oxidative damage is one of the earliest events of AD and is thought to play a crucial role in the onset and
development of the disease. Indeed, many studies show the biomarkers of oxidative stress to be elevated in AD brains. In
the present work the combined effects of HSV-1 infection and oxidative stress on Ab levels and autophagy
(neurodegeneration markers characteristic of AD) were investigated. Oxidative stress significantly potentiated the
accumulation of intracellular Ab mediated by HSV-1 infection, and further inhibited its secretion to the extracellular
medium. It also triggered the accumulation of autophagic compartments without increasing the degradation of long-lived
proteins, and enhanced the inhibition of the autophagic flux induced by HSV-1. These effects of oxidative stress were not
due to enhanced virus replication. Together, these results suggest that HSV-1 infection and oxidative damage interact to
promote the neurodegeneration events seen in AD.
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Introduction
Most of the human population is infected with Herpes simplex
virus type 1 (HSV-1), which causes life-long latent infections in
neurons. Different stimuli induce HSV-1 reactivation, which
usually leads to little more than renewed fever blisters. However,
on some occasions, new viral particles may spread within the
central nervous system, causing encephalitis, meningitis and even
epilepsy [1].
HSV-1 infection has also been associated with sporadic
Alzheimer’s disease (AD). The first evidence for this emerged
when epidemiological studies showed that people infected with
HSV-1 who also carried the apolipoprotein E type 4 allele were at
higher risk of developing the disease [2]. Other studies have now
connected HSV-1 with the main neuropathological hallmarks of
AD. For example, HSV-1 is now known to induce the
accumulation of b-amyloid peptide (Ab) [3,4,5,6], hyperpho-
sphorylated tau protein [7,8,9,10] and immature autophagic
vesicles [11,12] in several infection models. Recently, the presence
of IgM anti-HSV antibodies in serum - a marker of recent HSV
reactivation - was also correlated with an increased risk of
developing AD [13]. In addition, the analysis of data gathered in
genome-wide association studies involving thousands of Europeans
with AD and controls [14] identified a set of AD-linked gene
variants that might increase the susceptibility of the brain to HSV-
1 infection [15].
A growing number of studies also point to oxidative stress as key
in the pathogenesis of neurodegenerative diseases. The brain is
particularly susceptible to oxidative stress given its high polyun-
saturated fatty acid content, high oxygen demand, and low levels
of antioxidants [16]. An increase in markers of oxidative stress in
AD brains, including protein, RNA and DNA damage and lipid
peroxidation, has been reported, and experimental data from AD
animal models confirm the presence of oxidative stress during
early disease development [17]. In addition, oxidative stress plays
a prominent role in the progression of AD and contributes towards
the generation of Ab deposits and neurofibrillary tangles (reviewed
in [18]). However, the oxidative stress hypothesis has recently
come under fire, largely due to the negative results obtained in
clinical trials with antioxidants [19].
Herpesvirus infections are frequently associated with the
generation of oxidative stress in infected cells. HSV-1 has been
reported to induce the depletion of glutathione, the main
antioxidant defence [20,21], and to increase ROS levels and lipid
peroxidation [22]. In addition, numerous studies have shown
oxidative damage to occur in different cell and animal models of
HSV-1 infection (reviewed in [23,24]).
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The present work examines the interaction between oxidative
stress and HSV-1 infection in the appearance of neurodegener-
ation markers characteristic of AD. Both mild oxidative stress and
HSV-1 infection impaired the autophagic process and inhibited
Ab secretion. In addition, oxidative stress significantly enhanced
the effects of HSV-1 on Ab accumulation and secretion, as well as
the impairment of autophagy. These effects are not mediated by
the facilitation of infection since oxidative stress reduced the
quantity of viral DNA and proteins present and the formation of
viral infective particles in HSV-1-infected cells. The results
therefore suggest that the increase in oxidative stress concomitant
with aging promotes the neurodegeneration events associated with
HSV-1 infection.
Materials and Methods
Drugs, Plasmids and Antibodies
The rapamycin (0.2 mg/ml), xanthine (10 mM) and bafilomycin
A1 (100 nM) used in this study were obtained from Sigma.
Leupeptin (0.1 mM) and xanthine oxidase (50 mU/ml) were
obtained from Roche. 49, 6-diamidino-2-phenylindole (DAPI;
5 mg/ml) and ammonium chloride (20 mM) were purchased from
Merck.
The GFP-LC3 expression vector (pGFP-LC3) and the
mCherry-GFP-LC3 construct (dtLC3) were kindly provided by
T. Yoshimori and N. Mizushima [25] and by T. Johansen [26]
respectively. Goat anti-MAP LC3 (F14) was supplied by Santa
Cruz Biotech. Antibodies that recognized HSV-1 proteins were
supplied by DAKO (rabbit polyclonal anti-HSV-1), Sigma (rabbit
polyclonal anti-VP16) and Abcam [anti-HSV1 gC Envelope
Protein [3G9] and anti-HSV 1 ICP4 Immediate Early Protein
(10F1)]. Rabbit anti-GFP serum, rabbit polyclonal anti-Ab40 and
rabbit polyclonal anti-Ab42 unconjugated antibodies were pur-
chased from Invitrogen. Mouse monoclonal anti-tubulin antibody
was supplied by Sigma. The secondary antibodies used for
immunostaining were horseradish peroxidase-coupled and pur-
chased from VECTOR, or labelled with Alexa Fluor 488 or 555
dye and purchased from Invitrogen.
Cell Cultures and Transfection
SK-N-MC human neuroblastoma cells were obtained from the
American Type Culture Collection (HTB10). Cells stably
expressing human APP (SK-APP, cell line C2) and rat LC3 fused
to EGFP (SK-LC3) have been described elsewhere [5,27]. All SK-
N-MC cells were grown as monolayers in minimal Eagle’s medium
(MEM) supplemented with 10% heat-inactivated foetal calf serum
(FCS), 2 mM glutamine and 50 mg/ml gentamicin. Vero cells
were passaged in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 5% FCS, 2 mM glutamine and 50 mg/ml
gentamicin. All cells were grown at 37uC in a 5% CO2
atmosphere. For dtLC3 cell assays, SK-N-MC cells were
transiently transfected using the AmaxaH cell line NucleofectorH
method following the manufacturer’s instructions. Briefly, a pellet
of 46106 cells was resuspended in 100 ml of NucleofectorH
solution V, mixed with 15 mg of dtLC3 plasmid, and subjected to
nucleofection following the program C-009. After electroporation,
the cells were seeded onto the growth medium. Two days after
transfection, they were treated with the appropriate stimuli.
Infection Conditions and Exposure to Oxidative Stress
The wild-type HSV-1 strain KOS 1.1 was propagated and
purified as previously described [28]. SK-N-MC cells seeded in
complete MEM at 70–80% confluency were exposed to HSV-1 at
37uC for 1h. Mock infections were performed using a virus-free
suspension. Unbound virus was removed and the cells incubated
in complete MEM at 37uC. Time and multiplicity of infection
(moi; expressed as plaque-forming units [pfu] per millilitre)
conditions are indicated in each experiment. The particle to
PFU ratio was not determined. The infectious titres of HSV-1
were determined by plaque assay. Briefly, the titration of serially
diluted HSV-1 was performed in Vero cells grown in 24-well
plates. Cells were overlain with a mixture of DMEM containing
2% FCS and 0.7% agar. After 48 h the cells were fixed and
stained overnight with 1% crystal violet in 5% formaldehyde and
the plaques counted.
To induce oxidative stress, SK-N-MC cells were placed in fresh
medium for 1 h before X-XOD addition. Exposure times are
indicated in each experiment. In samples exposed to oxidative
stress and HSV-1, X-XOD was added during the time of virus
adsorption and maintained until the end of infection.
Measurement of Secreted and Intracellular Ab
For ELISA assays, SK-APP cells were mock-infected or infected
with HSV-1 and the conditioned media and cell lysates assayed for
human Ab40 and Ab42 using commercial ELISA sandwich kits
(Invitrogen) according to the manufacturer’s instructions. Briefly,
the conditioned media were treated with Complete Mini Protease
Inhibitor Cocktail (Roche) and concentrated 10-fold by lyophili-
zation. The cells were then suspended in lysis buffer (0.5% Triton
X-100, 2.5 mM EDTA in PBS containing the same protease
inhibitor cocktail) and sonicated for 60 s. Media and lysate
samples were added to ELISA plates pre-coated with mouse
monoclonal antibodies specific for the N-terminus of human Ab
(the capture antibody), followed by a rabbit anti-mouse antibody
specific for the amino acid sequence (amino acids 1–40 or 1–42) of
Ab (the detection antibody). The detection antibody bound was
quantified using a horseradish peroxidase-labelled anti-rabbit
antibody producing a coloured signal. The absorbance was read
at 450 nm within 30 min of the completion of the procedure.
Comparison with the Ab standard curve allowed the calculation of
absolute values for Ab40 and Ab42 (in pg/ml of incubation
medium, or pg/mg of protein).
Immunofluorescence Imaging
Immunofluorescence assays were performed on cells grown on
coverslips. These were fixed in 4% paraformaldehyde and
incubated with the appropriate primary and secondary antibodies.
DAPI (5 mg/ml) was added 10 min before the end of the
procedure to visualize the nuclei. GFP-LC3 and dtLC3 imaging
was performed in the same way but without antibody incubations.
All cells were examined using a Zeiss LSM510 META confocal
microscope or a Zeiss Axiovert 200 fluorescence microscope
equipped with 636 and 1006 oil-immersion objectives. Images
were captured by a Spot RT slider digital camera (Diagnostic)
using MetaMorphTM imaging software, and processed using
Adobe Photoshop CS4. Fluorescent-tagged dtLC3 spots were
counted and processed using Image J software (NIH).
Immunoblot Analysis
For immunoblot assays, cells were lysed in cell lysis buffer
(50 mM Tris-HCl pH 7.6, 300 mM NaCl and 0.5% Triton X-
100) containing Complete Mini Protease Inhibitor Cocktail
(Roche), and incubated for 30 min at 4uC. The protein
concentration of the lysates was quantified using the BCA Kit
(Pierce). Cell lysates were mixed with 26 Laemmli buffer,
sonicated, and heated for 5 min at 100uC. After electrophoretic
separation, the gels were blotted and stained with the appropriate
antibodies. A peroxidase-coupled antibody was used as the
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secondary antibody. Detection by enhanced chemiluminiscence
was performed using ECLTM Western Blotting Detection
Reagents (Amersham Biosciences) according to the manufacturer’s
instructions.
Analysis of Cell Viability
Cell viability was assessed using the 3-(4,5-dimethylthiazolyl-2)-
2,5-diphenyl tetrazolium bromide (MTT; Sigma) assay. Briefly,
M-96 plates were seeded at a rate of 56105 cells/well and, after
exposure to the different stimuli, incubated with 0.5 mg/ml MTT
for 3 h at 37uC. The MTT/formazan released from the cells
during overnight incubation at 37uC with 100 ml extraction buffer
(20% sodium dodecyl sulphate [SDS], 50% formamide adjusted to
pH 4.7 with 0.02% acetic acid and 0.025 N HCl) was then
determined. Optical densities were measured at 570 nm using an
automated Model 680 (Bio-Rad) microplate reader.
Long-lived Protein Degradation
SK-N-MC cells were labelled for 24 h in medium containing
60 mM unlabelled leucine and [3H]leucine (1 mCi/ml). They were
then washed and incubated for 24 h in MEM containing 2 mM
unlabelled leucine. After the chase, cells were incubated in MEM
plus rapamycin, or treated with X-XOD and infected with HSV-1
for 18 h. The cells and media were then collected and separately
precipitated by the addition of 10% ice-cold trichloroacetic acid
(TCA). Radioactivity was then measured in a liquid scintillation
counter. The percentage of long-lived protein degradation was
calculated as (TCA-soluble counts from medium)/(TCA-soluble
counts from medium)+(TCA-insoluble counts from the cells) [29].
HSV-1 DNA Quantification
The concentration of HSV-1 DNA was quantified by real-time
quantitative PCR as previously described [30] using the Custom
TaqMan assay (a specific assay for a sequence belonging to the
US12 viral gene), employing an ABI Prism 7900HT SD system
(Applied Biosystems) The quantification of human genomic DNA
was performed using an Assay-On-Demand probe specific for the
GAPDH housekeeping gene (Applied Byosystems; item nu
Hs99999905_m1). The quantification results were calculated as
viral DNA copy numbers per ng of genomic DNA.
Statistical Analysis
Bar graph values are expressed as means and standard errors of
the mean (SEM). Differences between groups were analysed using
the Student t-test. Significance was recorded at p,0.05 (*), 0.01
(**) and 0.001 (***). Before analysis, the largest and the smallest
variances were tested for homogeneity using the F-test.
Results
Oxidative Stress Enhances the Accumulation of
Intracellular Ab and the Inhibition of Ab Secretion
Induced by HSV-1 Infection
We have previously shown that HSV-1 causes the accumulation
of intracellular Ab and intensely inhibits its secretion [5]. In
addition, we reported that, in SK-N-MC cells, the xanthine/
xanthine oxidase (X-XOD) free radical generating system
regulates the metabolism/processing of the APP protein [31,32].
Since both events are putative primary events in AD pathogenesis,
the effects of oxidative stress on the neurodegeneration markers
induced by HSV-1 infection in neuronal cell models were
examined.
Ab levels in the SK-N-MC cell line overexpressing the human
APP protein (SK-APP) were examined by double labelling
immunofluorescence assays. Intracellular Ab was undetectable in
non-infected cells and in cells treated with X-XOD alone (Fig. 1A).
In contrast, a strong accumulation of both Ab species occurred in
HSV-1-infected cells in the presence and absence of X-XOD,
although Ab immunoreactivity was stronger in the X-XOD
treated cells (Fig. 1B). To quantify the effects of oxidative stress on
Ab production, ELISA assays with antibodies specific for Ab40
and Ab42 were performed. As suggested by the immunofluores-
cence experiments, treatment with X-XOD was unable to induce
any increase in intracellular Ab levels in non-infected cells, but in
HSV-1-infected cells it significantly enhanced the cell content of
both Ab isoforms (by about two-fold; Fig. 1C). X-XOD provoked
a marked suppression of secretion of Ab40 (two fold; p,0.001)
and Ab42 (six fold; p,0.01) to the extracellular medium, although
in both cases this reduction was smaller than that induced by
HSV-1. In addition, X-XOD potentiated the inhibition of Ab
secretion in HSV-1-infected cells, reducing to half the amount of
Ab40 secreted, and Ab42 to undetectable levels (Fig. 1D). Similar
results were obtained when SK-APP cells were infected at a lower
dose (moi 0.1 pfu/cell for 48 h), a situation more like that of
natural HSV-1 infection (Fig. 1E). X-XOD did not affect the
amount of APP either in mock- or HSV-1-infected cells, ruling out
the possibility that the modification of Ab levels induced by
oxidative stress was due to an alteration in APP content (Fig. 1F).
We previously described Ab to accumulate in autophagic
compartments in HSV-1-infected cells [5]. To determine whether
oxidative stress affected this accumulation, the distribution of
endogenous LC3, an autophagic vesicle marker, and Ab was
investigated in its presence. Confocal microscopy analysis revealed
immunoreactive Ab structures to colocalize with endogenous LC3-
positive vesicles in HSV-1-infected cells independent of their
oxidative status (Fig. 2). In contrast, Ab and LC3 immunoreac-
tivities were undetectable in mock-infected cells (data not shown).
Altogether, these results suggest that oxidative stress significantly
increases the accumulation of intracellular Ab and the inhibition
of its secretion (both of which are caused by HSV-1 infection) but
does not alter the accumulation of Ab in autophagosomes in HSV-
1-infected cells.
Oxidative Stress Enhances the Autophagosome
Accumulation Induced by HSV-1 Infection
LC3 is the most widely monitored autophagy-related protein.
LC3 is a ubiquitin-like protein initially synthesized in an
unprocessed form, proLC3, which is converted into a proteolyt-
ically processed form lacking amino acids from the C-terminus
termed LC3-I. LC3-I can be conjugated to phosphatidylethanol-
amine upon the activation of autophagy, leading to the formation
of the isoform LC3-II that remains bound to double membrane
autophagic vesicles [25]. We previously reported HSV-1 to induce
the accumulation of autophagosomes in a viral dose- and time-
dependent manner [12]. To determine whether oxidative stress
affected this, the distribution of GFP-LC3 in SK-N-MC cells
infected with HSV-1 and stably expressing the GFP-LC3 fusion
protein (SK-LC3) was monitored in the presence of X-XOD
(Fig. 3A). Fluorescence microscopy analysis showed a cytosolic
distribution but few GFP-LC3 spots were seen in non-treated,
non-infected cells. In contrast, in X-XOD-treated or infected cells,
a strong increase was seen in the number of cells with numerous
GFP-LC3 spots. Certainly, the accumulation of GFP-LC3 spots
appeared greater in HSV-1-infected cells treated with X-XOD
than in non-treated infected cells (Fig. 3A).
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To better quantify the effects of oxidative stress, GFP-LC3-II
levels were analysed by immunoblotting (Fig. 3B). Consistent with
the data obtained in the fluorescence microscopy experiments,
increased levels of GFP-LC3-II were observed in SK-LC3 cells
following the addition of X-XOD. These results agree with a
recent report from our group showing an increase in endogenous
LC3-II in SK-N-MC cells treated with X-XOD [31], and confirm
that oxidative stress induces autophagosome accumulation in
human neuroblastoma cells. HSV-1 infection also induced a
strong increase of GFP-LC3-II levels. A marked increase in GFP-
LC3-II following X-XOD addition was also observed in HSV-1-
infected cells by densitometric analysis of the GFP-LC3 bands
(Fig. 3B). These data indicate that oxidative stress not only induces
autophagosome accumulation but enhances the autophagosome
accumulation induced by HSV-1.
Oxidative Stress Enhances the Inhibition of the
Autophagic Flux Provoked by HSV-1
The accumulation of autophagosomes at determined time
points results from either an increase in the rate of their formation
or a reduction in autophagosome turnover. To investigate the
cause of this accumulation in cells subjected to oxidative stress, a
series of experiments was performed to measure the autophagic
flux. Autophagic flux refers to the entire process of autophagy,
including the delivery of cargos to lysosomes, their subsequent
breakdown, and the release of the resulting macromolecules to the
cytosol [33]. The effect of oxidative stress on LC3-II turnover in
the presence of the lysosomal inhibitors leupeptin and ammonium
chloride was determined by immunoblotting (Fig. 3B). A strong
increase in GFP-LC3-II levels (,9-fold) was observed in mock-
infected cells in the presence of lysosomal inhibitors, indicating the
high level of autophagic flux in SK-LC3 cells. In contrast, the
addition of X-XOD only caused a modest increase in GFP-LC3-II
levels (,1.6-fold) (Fig. 3C). We recently reported similar results
when the effect of oxidative stress on endogenous LC3 levels was
examined in the presence of lysosomal inhibitors [31]. These
inhibitors induced a smaller increase in GFP-LC3-II levels in
HSV-1-infected cells (,1.4-fold). The increase induced by
lysosomal inhibitors in cells treated with X-XOD, or infected
with HSV-1, was completely abolished when both stimuli were
Figure 1. Effects of oxidative stress on Ab levels in HSV-1-infected SK-APP cells. A) Confocal microscopy images showing Ab40, Ab42 and
gC immunoreactivities in SK-APP cells non-treated or treated with X-XOD for 18 h. Scale bar: 10 mm. B) Confocal microscopy images showing Ab40
and Ab42 immunoreactivities in cells infected with HSV-1 at a moi of 10 for 18 h (identified with an antibody that recognizes the glycoprotein C of
HSV-1) in the presence and absence of X-XOD. Green (Ab) and red (gC) channels were merged. Scale bar: 10 mm. C) ELISA analysis of intracellular Ab
levels, normalized by the amount of total protein, in HSV-1-infected cells at a moi of 10 for 18 h in the presence of X-XOD (**p,0.01). D and E) ELISA
analysis of Ab levels in the medium of cells treated with X-XOD and infected with HSV-1 at a moi of 10 for 18 h (D) or 0.1 for 42 h (E) (**p,0.01;
***p,0.001). In (C-E) the results are the means of at least four experiments. Bars show the SEM. F) Analysis of APP levels by Western blotting in SK-N-
MC cells infected with HSV-1 at a moi of 10 for 18 h. The effect of X-XOD is shown. A control ensuring equal loading - a tubulin blot - is also shown.
The ratio of APP to tubulin is shown below the blots. The blots are representative of four independent experiments.
doi:10.1371/journal.pone.0075842.g001
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combined (Fig. 3C). Taken together, these results suggest that
autophagy is induced as a consequence of oxidative stress and
HSV-1 infection, but that the final stages of autophagy are
inhibited.
The accumulation of LC3-II can be obtained by interrupting
the autophagosome-lysosome fusion step. To determine whether
this is impaired by oxidative stress, SK-N-MC cells were
transfected with a tandem repeat GFP-mCherry-LC3 construct
[26]. This reporter shows dual red-green fluorescence in
phagophores and autophagosomes, but loses the GFP signal in
the acidic environment of autolysosomes. X-XOD treatment
increased the appearance of both GFP-LC3 and mCherry-LC3
fluorescent spots and their colocalization (‘‘yellow’’ vesicles,
indicative of autophagosomes) compared to that seen in non-
treated cells. A significant increase in the number of yellow-
fluorescence vesicles in HSV-1-infected cells was also seen,
confirming previous results [12]. In contrast, control and
rapamycin-treated cells demonstrated functional autophagy with
a preponderance of autolysosomes (‘‘red-only’’ LC3 vesicles)
(Fig. 4A). These data suggest that X-XOD blocks the autophagic
flux. To quantify the inhibition of autophagosome-lysosome
fusion, the proportion of autophagosomes (‘‘yellow’’ vesicles) was
calculated. This proportion increased greatly in cells exposed to X-
XOD (58%) or HSV-1 (80%) compared to control and
rapamycin-treated cells (35% and 24% respectively). It further
increased to 90% when the cells were treated with both X-XOD
and HSV-1, although this increase was not statistically significant.
This ratio was similar to that obtained in cells treated with
bafilomycin A1, an inhibitor of autophagosome-lysosome fusion
(Fig. 4B).
Finally, the effect of oxidative stress on autophagic protein
degradation was tested using long-lived protein degradation assay,
a well established method for measuring autophagic flux [33]. As
previously reported, HSV-1 did not affect the long-lived protein
degradation rate [12]. Rapamycin, a classical inducer of autoph-
agy, significantly increased the degradation of long-lived cell
proteins as expected. In contrast, X-XOD treatment resulted in a
significant reduction of protein degradation, both in mock- and
HSV-1-infected cells (Fig. 4C).
These results suggest that oxidative stress provokes inefficient
fusion between autophagosomes and lysosomes, resulting in
reduced autophagic protein degradation and potentiation of the
impairment of autophagy induced by HSV-1 infection.
Figure 2. Oxidative stress does not affect the autophagosomal
localization of Ab in HSV-1-infected cells. Confocal images
obtained with anti-Ab and anti-LC3 antibodies showing endogenous
LC3 and Ab patterns in HSV-1-infected SK-APP cells at a moi of 10 for
18 h in the presence and absence of oxidative stress (X-XOD).
Colocalization is shown by yellow fluorescence signals in the merged
panels. Scale bar: 10 mm.
doi:10.1371/journal.pone.0075842.g002
Figure 3. Effects of oxidative stress on autophagy. A) SK-LC3 cells were simultaneously treated with X-XOD and infected with HSV-1 at a moi
of 10 for 18 h and the cellular distribution of GFP-LC3 assessed by fluorescence microscopy. Scale bar: 10 mm. B) Analysis of GFP-LC3 levels by
Western blotting with an anti-GFP antibody in SK-LC3 cells simultaneously treated with X-XOD and infected with HSV-1 (moi of 10 for 18 h). The
effects of the lysosomal inhibitors leupeptin and ammonium chloride are shown. Blots are representative of four independent experiments; a tubulin
blot was performed as a loading control. The ratio of LC3-II to tubulin is shown below the blots. C) The graph represents the fold increase in GFP-LC3-
II levels, normalized by tubulin, in leupeptin/NH4Cl-treated cells compared to non-treated cells in all conditions assayed in (B).
doi:10.1371/journal.pone.0075842.g003
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Oxidative Stress Inhibits HSV-1 Replication
The additive effects of oxidative stress on neurodegeneration
events induced by HSV-1 could be argued due to the facilitation of
infection. To test this hypothesis, the levels of several viral proteins,
viral DNA and infectious particles were monitored in the presence
of the X-XOD system.
To determine whether oxidative stress enhances viral entry into
SK-N-MC cells, the latter were simultaneously treated with X-
XOD and infected with HSV-1 and the number of infected cells at
early stages of infection (3 and 5 h.p.i. [hours post-infection])
determined by immunofluorescence analysis using a specific
antibody for ICP4 (Fig. 5A). ICP4 is coded for by an
immediate-early gene, the expression of which begins at early
stages of infection, and it accumulates in the nucleus of infected
cells. The quantification of ICP4-positive cells revealed the
percentage of infected cells not to be modified by X-XOD
treatment (Fig. 5B). Consistent with these results, immunoblotting
showed the ICP4 levels to remain constant in HSV-1-infected cells
in the presence of X-XOD (Fig. 5C). These data indicate that
oxidative stress does not facilitate viral entry into human
neuroblastoma cells.
To determine whether oxidative stress has any effect on viral
protein synthesis, the expression of representative viral proteins at
late stages of infection (18 h.p.i.) was assessed in SK-N-MC cells in
the presence of X-XOD. Immunoblotting analyses were per-
formed using antibodies specific for ICP4 (an immediate early
protein, the expression of which begins before HSV-1 DNA
replication takes place), VP16 (a c1 late protein, the expression of
which is not strictly dependent on viral DNA synthesis) and
glycoprotein C (gC, which belongs to the class of c2 ‘‘true late’’
genes, the expression of which requires viral DNA synthesis).
When SK-N-MC cells were infected with different viral doses (moi
1 and 10) in the presence of X-XOD, no differences in the amount
of ICP4 were observed compared to non-treated infected cells at
18 h.p.i. (Fig. 6A). Similar levels of VP16 were detected in HSV-1-
infected cells irrespective of the addition of X-XOD (Fig. 6A).
Finally, X-XOD treatment greatly reduced gC levels in infected
cells (67% of reduction at a moi of 1 and 55% at a moi of 10;
Fig. 6A), indicating that oxidative stress only altered the levels of
viral proteins whose expression is strictly dependent on viral DNA
synthesis. When the levels of HSV-1 proteins were assessed in SK-
N-MC cells infected for longer, i.e., when a replication cycle had
been completed (moi 0.1 for 42 h), large reductions in ICP4, VP16
and gC levels were recorded (Fig. 6B). These results indicate that
Figure 4. Oxidative stress and HSV-1 infection induced inefficient fusion between autophagosomes and lysosomes. A) SK-N-MC cells
were transfected with dtLC3 and then infected with HSV-1 at a moi of 10 for 18 h, or treated with bafilomycin A1 (baf A1), rapamycin (rapa) or X-XOD
for 18 h. Representative confocal microscopy images are shown; the GFP (green) and mCherry (red) channels were merged. Scale bars: 10 mm. B)
Graphic representation of the proportion of autophagosomes (yellow dots). The number of fluorescent bodies in 100 cells was counted for each
condition. C) Degradation of long-lived proteins in SK-N-MC cells infected with HSV-1 at a moi of 10 for 18 h in the presence or absence of X-XOD.
Rapamycin (rapa) was used as a positive control of autophagy stimulation. Results are the mean6 SEM of three independent experiments performed
in triplicate (*p,0.05; ***p,0.001).
doi:10.1371/journal.pone.0075842.g004
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oxidative stress reduces viral protein levels in the second
replication cycle. It may therefore inhibit the replication of viral
DNA and protect from HSV-1-induced cell death. To test this
hypothesis, viral DNA replication was analysed in real-time
quantitative PCR assays (Fig. 7A). X-XOD caused a significant
reduction in viral DNA levels under the different moi conditions
assayed (a 55% and 33% reduction at moi 1 and 10 respectively at
18 h.p.i, and .95% at moi 0.1 at 42 h.p.i). Finally, the effect of
oxidative stress on HSV-1 titres was measured by plaque assays. A
strong reduction in the production of infectious HSV-1 particles
was seen after X-XOD addition (.90% in all conditions assayed;
Fig. 7B). Since oxidative stress induced the inhibition of HSV-1
replication, its effect on the viability of HSV-1-infected cells was
also tested. We have previously reported that the oxidative stress
induced by the X-XOD treatment leads to apoptotic cell death in
human neuroblastoma cells, starting at 36 h [34]. In the present
work, MTT assays revealed significantly reduced cell viability after
42 h of exposure. At 18 h.p.i., the number of dead cells increased
with viral dose, reaching , 40% at a moi of 10 (Fig. 7C). When
the SK-N-MC cells were infected at a moi 0.1 for 48 h, a situation
more like that of natural HSV-1 infection, the proportion of dead
cells reached 40%. Treatment with X-XOD led to a significant
reduction in cell death in HSV-1-infected cells at all viral doses
and times assayed (Fig. 7C).
Taken together, these results confirm that oxidative stress
reduces HSV-1 replication and protects against cell death
provoked by the virus in human neuroblastoma cells.
Discussion
Viral infections are commonly associated with the appearance
of oxidative stress in infected cells. Certainly, HSV-1 shifts the
intracellular redox balance towards a pro-oxidant state (reviewed
in [23,24]). Oxidative damage could therefore be an infection-
induced mechanism of neuronal injury. However, the interplay
between oxidative stress and HSV-1 infection has not been
extensively studied and, until now, it was unknown whether these
two factors interact in some way to promote neurodegeneration.
The free radical-generating X-XOD system has been employed
in the experimental induction of oxidative stress [35]. In earlier
work we developed a human neuronal cell model of mild oxidative
stress using this system that allowed the analysis of free radical-
induced events preceding cell death. We recently reported the X-
XOD system to alter cholesterol biosynthesis [34] and APP
metabolism/processing [31,32]. Since X-XOD-modulated pro-
cesses are altered in the AD brain, we investigated the effects of X-
XOD on AD-like neurodegeneration events induced by HSV-1
infection.
We have previously shown that HSV-1 impairs two processes
intimately related to neurodegeneration: autophagy and the APP
proteolytic process. HSV-1 induces an abortive autophagic
response resulting in autophagosome accumulation [12]. Addi-
tionally, the intracellular accumulation of Ab in autophagic
compartments induced by HSV-1 infection is caused by the
inhibition of Ab secretion and the failure of Ab degradation by
autophagy [5]. We therefore performed a series of experiments to
examine the relationship between HSV-1 and oxidative stress. In
Figure 5. Effects of oxidative stress on HSV-1 entry. A) Immunofluorescence analysis of HSV-1-infected SK-N-MC cells at a moi of 10 in the
presence and absence of X-XOD. The immunoreactivity of ICP4 protein is shown at 3 and 5 hours post-infection (h.p.i.). Nuclei are stained with DAPI.
Scale bar: 20 mm. B) Quantification of infected cells by ICP4 staining. The graph shows the percentage of ICP4-positive cells. At least 400 nuclei were
counted for each condition. C) Analysis of ICP4 levels by Western blotting in SK-N-MC cells infected with HSV-1 at a moi of 1 and 10 for 3 h and 5 h, in
the presence and absence of X-XOD.
doi:10.1371/journal.pone.0075842.g005
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human neuroblastoma cells, oxidative stress was found to
significantly enhance the accumulation of intracellular Ab and
the inhibition of Ab secretion mediated by HSV-1 infection. With
respect to autophagy, oxidative stress potentiated the accumula-
tion of autophagic compartments as a result of an increase of the
inhibition of autophagic flux in infected cells. Consistent with these
data, oxidative stress did not affect Ab accumulation in autophagic
vesicles in infected cells. In earlier work, we showed that mild
oxidative stress increases LC3-II and p62 levels, both substrates of
autophagic process, suggesting that the observed accumulation of
autophagosomes was due to the interruption of autophagic flux
[31]. In this report, pH-sensitive double-tagged mCherry-GFP-
LC3 assay confirms that oxidative stress induces abnormal
autophagy via inefficient fusion between autophagosomes and
lysosomes in neuronal cells. This oxidative stress-mediated
inhibition of autophagic flux could contribute to the increased
accumulation of intracellular Ab in autophagosomes in HSV-1-
infected cells. It has been reported that HSV-1 is able to modulate
autophagy through two viral proteins. The HSV-1 neurovirulence
protein ICP34.5 blocks autophagy by promoting eIF2a dephos-
phorylation and by inhibiting the essential autophagy protein
beclin 1 [36,37]. In addition, the late viral protein Us11 is also able
to block autophagy by direct inhibition of the double-stranded
RNA-dependent protein kinase PKR [38]. These findings reveal
that HSV-1 infection strongly controls the autophagic process
through multiple mechanisms.
The question arises as to whether the enhancement of
neurodegeneration events provoked by oxidative stress is merely
due to greater facilitation of infection. However, oxidative stress
was seen to have no effect on the number of infected cells at early
stages of infection or on the levels of immediate early (a) and leaky
late (c1) proteins. This indicates that oxidative stress does not affect
virus entry or the transcription of replication-independent genes.
In addition, a significant reduction in true late protein (c2) gC
levels was observed. The expression of true late c2 class genes
strictly depends on viral DNA synthesis. This suggests that the viral
DNA production is affected by oxidative stress. Indeed, analysis of
HSV-1 DNA replication showed a significant reduction in viral
DNA levels and an inhibition of the formation of new infectious
particles induced by oxidative stress. Consistent with our results,
the cellular antioxidant chaperone Hsp27 is required for efficient
HSV-1 replication [39] and the accumulation of oxidized proteins
was enhanced in infected cells in the absence of Hsp27 [40].
However, the inhibition of the formation of new infectious
particles in the presence of oxidative stress was much stronger
than the inhibition of viral DNA replication, suggesting that an
additional defect in a late stage of infection might occur (e.g.
maturation of viral particle). The present results therefore confirm
Figure 6. Effects of oxidative stress on HSV-1 protein
expression. The accumulation of viral proteins ICP4, VP16 and gC
was analysed by immunoblotting in SK-N-MC cells simultaneously
treated with X-XOD and infected with HSV-1 at a moi of 1 and 10 for
18 h (A) or at a moi of 0.1 for 42 h (B). The blots shown are
representative of three independent experiments. A tubulin blot was
performed as a loading control. In all blots, the ratio of viral proteins to
tubulin is shown below the blots.
doi:10.1371/journal.pone.0075842.g006
Figure 7. Oxidative stress reduces HSV-1 replication and
increases cell viability of infected cells. A) Quantification of viral
DNA by real-time quantitative PCR in SK-N-MC cells simultaneously
treated with X-XOD and infected with HSV-1 at a moi of 1 and 10 for
18 h or at a moi of 0.1 for 42 h. B) Intracellular (intra) and extracellular
(extra) viral titres were determined by plaque assays in SK-N-MC cells
infected under the same conditions as in (A). In (A) and (B), the data
represent the mean 6 SEM of five experiments performed in triplicate
and are expressed as a percentage with respect to untreated cells (- X-
XOD) (*p,0.05; **p,0.01; ***p,0.001). C) The cell viability of mock
and HSV-1-infected SK-N-MC cells exposed to X-XOD was monitored
using the MTT reduction assay. Cells were infected with HSV-1 at a moi
of 1 and 10 for 18 h or at a moi of 0.1 for 42 h. Values are expressed
relative to the optical density of untreated mock-infected cells. The data
shown represent the mean 6 SEM for four independent experiments
performed in triplicate (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0075842.g007
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that oxidative stress reduces HSV-1 replication and protects
human neuroblastoma cells from death provoked by HSV-1
infection. In addition, they show that the strengthening of
neurodegeneration markers induced by oxidative stress in HSV-
1-infected cells cannot be attributed to any facilitation of infection.
Further investigations are needed to better understand the basic
mechanisms involved in these alterations. In this respect, we are
currently engaging in microarray analyses of differential gene
expression in cellular infection models in order to identify the
genes and/or pathways involved in the effects of oxidative stress on
HSV-1 infection.
Few reports exist on the effects of oxidative agents on HSV-1
infection. In agreement with the present results, a recent report
showed that HSV-1 contains catalase, an enzyme that catalyses
the decomposition of hydrogen peroxide. This suggests viral
replication needs to be protected from oxidising environments
[41]. In contrast, Arimoto et al. showed hydrogen peroxide to
promote the release of HSV-1 from epithelial cells, increasing the
amount of cell-free virus without reducing levels of cell-associated
virus [42]. The difference between the present results and those
obtained by Arimoto et al. might be explained in several ways: i)
the use of different cell types, ii) maintaining the oxidation inducer
throughout the experiment in the present work, but adding it just
2 h before the end of infection in the work of these other authors,
and iii) the intensity of the oxidative damage generated. Hydrogen
peroxide at the concentration used in the Arimoto study (1 and
5 mM) acts as a strong oxidizing agent that causes a significant
increase in cell death just 2 h after its addition, whereas the X-
XOD system used in the present work induces mild oxidative
stress that does not affect cell viability at 18 h.
Since oxidative stress blocks HSV-1 replication, a reduction in
the neurodegenerative effects induced by infection might be
expected. However, the accumulation of autophagosomes and
intracellular Ab observed in infected cells treated with X-XOD
was significantly stronger than in infected but non-X-XOD-
treated cells. Consistent with this finding, previous experiments
performed in human neuronal cells in the presence of the viral
DNA synthesis inhibitor phosphonoacetic acid showed that a
productive infection is not required to induce all the AD-like
neurodegeneration events [5,7,12]. Since the non-treated cells
were more susceptible to HSV-1 replication than were the X-
XOD-treated cells, the rapid lysis of the former may have
precluded stronger Ab and autophagosome production. In this
scenario, oxidative stress might attenuate the infection process,
maintaining the negative effects of infection on the host cells for
longer.
Another possibility is that oxidative damage provides a second
mechanism by which HSV-1-induced neuronal injury may occur.
Consequently, oxidative stress produced in vitro (X-XOD treat-
ment) or in vivo (microglial response) may enhance the neurode-
generative effects provoked by HSV-1. In line with this hypothesis,
De Chiara et al. [3] found that antioxidant compounds prevented
the formation of Ab oligomers induced by HSV-1 in SH-SY5Y
human neuroblastoma cells, suggesting that oxidative stress is
involved in this process. In addition, alterations in the redox state
have been associated with the appearance of the characteristic
pathological anomalies that accumulate in AD brains. Indeed,
numerous studies have shown that pro-oxidant agents can increase
the production of Ab [43,44], and a recent report has revealed
that antioxidant therapy interrupts the progression of amyloid and
tau pathology in a mouse model of AD [45]. Further, several
kinases involved in tau phosphorylation belong to the stress-
activated protein kinase family known to be activated during
oxidative stress [46].
In summary, the present findings indicate that, in the present
model, mild oxidative stress caused by the X-XOD system strongly
affects the neurodegeneration markers induced by HSV-1; it
significantly enhances the effects of HSV-1 on Ab accumulation
and secretion and contributes to the impairment of autophagy
observed in HSV-1-infected cells (thus increasing the inhibition of
autophagic flux). Interestingly, HSV-1 replication is severely
compromised in cells subjected to oxidative stress; the effects of
oxidative stress on neurodegeneration events cannot, therefore, be
a consequence of an increase in HSV-1 replication. Taken
together, the present results identify an interesting link between
oxidative stress and HSV-1 infection; their interaction may
promote neurodegeneration events in AD brains.
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